Consolidated statement of income
The Specialty Chemicals business is reported as discontinued operations. Therefore, the results of the Specialty Chemicals business are included on the line "Profit for the period from discontinued operations" in the consolidated statement of income for 2017, as well as 2016.
Fourth quarter |
|
January-December |
||||
2016 * |
2017 |
in € millions |
2016 * |
2017 |
||
|
||||||
Continuing operations |
||||||
2,291 |
2,283 |
Revenue |
9,434 |
9,612 |
||
(1,263) |
(1,300) |
Cost of sales |
(5,098) |
(5,378) |
||
1,028 |
983 |
Gross profit |
4,336 |
4,234 |
||
(884) |
(840) |
SG&A costs |
(3,401) |
(3,370) |
||
(12) |
(4) |
Other results |
(12) |
(39) |
||
132 |
139 |
Operating income |
923 |
825 |
||
(19) |
(15) |
Net financing expenses |
(91) |
(78) |
||
3 |
2 |
Results from associates and joint ventures |
18 |
17 |
||
116 |
126 |
Profit before tax |
850 |
764 |
||
(18) |
(81) |
Income tax |
(234) |
(253) |
||
98 |
45 |
Profit for the period from continuing operations |
616 |
511 |
||
|
|
|
|
|
||
Discontinued operations |
||||||
52 |
47 |
Profit for the period from discontinued operations |
436 |
393 |
||
150 |
92 |
Profit for the period |
1,052 |
904 |
||
|
|
|
|
|
||
Attributable to |
||||||
133 |
75 |
Shareholders of the company |
970 |
832 |
||
17 |
17 |
Non-controlling interests |
82 |
72 |
||
150 |
92 |
Profit for the period |
1,052 |
904 |
||